Dataset Information


Instrumental variable methods for a binary outcome were used to informatively address noncompliance in a randomized trial in surgery.

ABSTRACT: Randomization can be used as an instrumental variable (IV) to account for unmeasured confounding when seeking to assess the impact of noncompliance with treatment allocation in a randomized trial. We present and compare different methods to calculate the treatment effect on a binary outcome as a rate ratio in a randomized surgical trial.The effectiveness of peeling versus not peeling the internal limiting membrane of the retina as part of the surgery for a full thickness macular hole. We compared the IV-based estimates (nonparametric causal bound and two-stage residual inclusion approach [2SRI]) with standard treatment effect measures (intention to treat, per protocol and treatment received [TR]). Compliance was defined in two ways (initial and up to the time point of interest). Poisson regression was used for the model-based approaches with robust standard errors to calculate the risk ratio (RR) with 95% confidence intervals.Results were similar for 1-month macular hole status across methods. For 3- and 6-month macular hole status, nonparametric causal bounds provided a narrower range of uncertainty than other methods, though still had substantial imprecision. For 3-month macular hole status, the TR estimate was substantially different from the other point estimates.Nonparametric causal bound approaches are a useful addition to an IV estimation approach, which tend to have large levels of uncertainty. Methods which allow RRs to be calculated when addressing noncompliance in randomized trials exist and may be superior to standard estimates. Further research is needed to explore the properties of different IV methods in a broad range of randomized controlled trial scenarios.


PROVIDER: S-EPMC5862096 | BioStudies | 2018-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5395991 | BioStudies
2019-01-01 | S-EPMC6786180 | BioStudies
2019-01-01 | S-EPMC6585771 | BioStudies
2018-01-01 | S-EPMC6224594 | BioStudies
2017-01-01 | S-EPMC5468526 | BioStudies
2020-01-01 | S-EPMC7183155 | BioStudies
1000-01-01 | S-EPMC5541320 | BioStudies
2008-01-01 | S-EPMC2607251 | BioStudies
1000-01-01 | S-EPMC6054750 | BioStudies
2020-01-01 | S-EPMC7160520 | BioStudies